These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8829443)

  • 41. The differential contribution of dopamine D(1) and D (2) receptors to mu-opioidergic immunomodulation.
    Cheido MA; Idova GV
    Neurosci Behav Physiol; 2007 Sep; 37(7):721-4. PubMed ID: 17763992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of the nucleus accumbens in stimulation of the immune response in rats after activation of opioid mu receptors with DAGO.
    Devoino LV; Cheido MA; Al'perina EL
    Neurosci Behav Physiol; 2002; 32(5):529-32. PubMed ID: 12403006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of the rat caudate nucleus in the immunostimulatory effect of DAGO.
    Devoino LV; Cheido MA; Al'perina EL
    Neurosci Behav Physiol; 2001; 31(3):323-6. PubMed ID: 11430578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for a role of dopaminergic mechanisms in the immunostimulating effect of mu-opioid receptor agonist DAGO.
    Devoino L; Cheido M; Alperina E; Idova G
    Int J Neurosci; 2003 Oct; 113(10):1381-94. PubMed ID: 14534037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Differential contribution of dopamine D1 and D2 receptors in the mu-opioidergic immunomodulation].
    Cheĭdo MA; Idova GV
    Ross Fiziol Zh Im I M Sechenova; 2006 May; 92(5):546-51. PubMed ID: 16869283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of opioid peptides on immunomodulation].
    Cheĭdo MA; Idova GV
    Ross Fiziol Zh Im I M Sechenova; 1998 Apr; 84(4):385-90. PubMed ID: 9742618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dopaminergic mechanisms in the immunostimulating effect of mu-opioid receptors].
    Cheĭdo MA; Idova GV
    Biull Eksp Biol Med; 1996 Apr; 121(4):373-5. PubMed ID: 8829443
    [No Abstract]   [Full Text] [Related]  

  • 49. [Mu-opioidergic immunomodulation: the neurochemical basis].
    Cheĭdo MA; Idova GV
    Usp Fiziol Nauk; 2009; 40(2):12-25. PubMed ID: 19505020
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.